RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF ROBIT PLC
ROBIT PLC STOCK EXCHANGE RELEASE 15 MARCH 2023 AT 3.30 PM
RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF ROBIT PLC
The Annual General Meeting of Robit Plc held today on 15 March 2023 passed the following resolutions:
1. Adoption of the financial statements and consolidated financial statements
The General Meeting adopted the financial statements and consolidated financial statements for the financial period 1 January–31 December 2022.
2.Use of the profit shown in the balance sheet and deciding on the payment of dividends
The General Meeting resolved that the profit for the financial year 1 January–31 December 2022 be transferred to the previous accounting period’s retained earnings account and that no dividend be paid based on the adopted balance sheet for the financial year 1 January–31 December 2022.
3. Resolution to distribute funds from the company’s invested unrestricted equity fund
The General Meeting resolved that EUR 0.02 per outstanding share be paid from the company’s distributable funds to the shareholders. The distribution of funds will be executed as repayment of capital from the company’s invested unrestricted equity fund.
A shareholder who is entered in the company’s shareholder register maintained by Euroclear Finland Ltd on the record date of the repayment of capital on 22 September 2023 is entitled to a repayment. The repayment of capital shall be distributed on 29 September 2023.
4. Resolution on discharge from liability
The General Meeting resolved to discharge the members of the Board of Directors and the managing director from liability for the financial period ending 31 December 2022.
5. Handling of remuneration report for governing bodies
The General Meeting resolved to adopt the remuneration report for governing bodies. In accordance with the Finnish Limited Liability Companies Act, the decision is advisory.
6. Composition and remuneration of the Board of Directors
The General Meeting resolved that the Board of Directors consists of six (6) members.
The annual remuneration for the Chairman of the Board is EUR 55 000, and for each Board Member is EUR 30 000, of which 40% will be paid as shares and the remaining 60% as an advance tax withheld and paid to the Finnish Tax Administration by the company.
In addition, a compensation of EUR 500 will be paid to the Board Members for each board meeting or committee meeting they have attended. Should the meeting be organised remotely, and it lasts maximum of 1 hour, will the compensation be EUR 250 per meeting. Additionally, other costs, such as travel and lodging expenses, will also be compensated.
The annual remuneration for the entire term of office will be paid to the Chairman of the Board and to the Board Members in December 2023. The shares that form part of the remuneration payable to the Chairman of the Board and to the Board Members can be new shares issued by the company or shares acquired thereby pursuant to an authorisation provided to the Board of Directors by the General Meeting. The receiver of the remuneration will pay the applicable transfer tax.
Mikko Kuitunen, Anne Leskelä, Harri Sjöholm, Markku Teräsvasara and Eeva-Liisa Virkkunen were re-elected as members of the Board. Lasse Aho was elected as a new member of the Board.
7. Election and remuneration of auditor
PricewaterhouseCoopers Oy (PwC) was elected as the company’s auditor for a term that will continue until the end of the next Annual General Meeting. PricewaterhouseCoopers Oy has notified the company that Authorised Public Accountant, Markku Katajisto, will serve as the company’s principal responsible auditor.
The General Meeting resolved to pay the auditor’s remuneration in accordance with a reasonable invoice approved by the company.
8. Authorising the Board of Directors to decide on the acquisition of the company’s own shares and/or accepting them as a pledge
The General Meeting resolved to authorise the Board of Directors to resolve on the acquisition of a maximum of 2 117 990 shares of the company’s own shares and/or accepting the same number of the company’s own shares as a pledge, in one or several tranches by using funds in the unrestricted shareholders’ equity. The maximum total of shares that will be acquired and/or accepted as a pledge corresponds to 10% of all shares in the company as of the date of the summons to the Annual General Meeting. However, the company cannot, together with its subsidiary companies, own or accept as a pledge altogether more than 10% of its own shares at any point in time. The company’s shares may be purchased under this authorisation solely by using unrestricted shareholders’ equity.
The shares will be acquired otherwise than in proportion to the share ownership of the shareholders via public trading arranged by Nasdaq Helsinki Ltd at the market price on the date on which the acquisition is made or otherwise at a price formed on the market. The authorisation shall be used e.g. for the purposes of implementing the company’s share-based incentive systems or for other purposes as decided by the Board of Directors.
It was resolved that the authorisation revokes the authorisation granted by the General Meeting on 22 March 2022 to decide on the acquisition of the company’s own shares.
The authorisation is valid until the closing of the next Annual General Meeting, however, no longer than until 30 June 2024.
9. The Board of Directors was authorised to resolve on a share issue and the issuance of special rights entitling to shares
The Annual General Meeting resolved to authorise the Board of Directors to resolve on a share issue and on the issuance of special rights entitling to shares as referred to in Chapter 10 Section 1 of the Finnish Limited Liability Companies Act, in one or more tranches, either against or without consideration.
The number of shares to be issued, including shares to be issued on the basis of special rights, may not exceed 2 117 990, which amounts to 10% of all shares in the company as of the date of the summons to the Annual General Meeting. The Board of Directors may decide to either issue new shares or to transfer any treasury shares held by the company.
The authorisation entitles the Board of Directors to decide on all terms that apply to the share issue and to the issuance of special rights entitling to shares, including the right to derogate from the shareholders’ pre-emptive right. The authorisation shall be used e.g. for the purposes of strengthening the company’s balance sheet and improving its financial status or for other purposes as decided by the Board of Directors.
The authorisation is valid until the closing of the next Annual General Meeting, however, no longer than until 30 June 2024. The authorisation revokes all previously granted, unused authorisations to decide on a share issue and the issuance of options or other special rights entitling to shares.
10. Amendment of the Articles of Association
The Annual General Meeting resolved that an addition will be made to section 8 § of the Articles of Association to include the possibility by the Board of Directors, at their discretion, to arrange a General Meeting as a hybrid meeting. In addition, the amendment will enable arranging a General Meeting as a virtual meeting without a meeting venue.
Pursuant to the resolution by the Annual General Meeting, section 8 § of the Articles of Association will read as follows after the amendment:
“8 § The invitation to the General Meeting is published on the company’s website no earlier than two months and no later than 21 days before the meeting, but always at least nine (9) days before the reconciliation date of the General Meeting as defined in the Limited Liability Companies Act.
The Board of Directors may decide that shareholder may exercise their full decision-making powers in real time during the General Meeting using telecommunications and technical means (hybrid meeting).
The Board of Directors may decide that the General Meeting is arranged without a meeting venue in a manner where shareholders exercise their full decision-making powers in real time during the General Meeting using telecommunications and technical means (virtual meeting).
A shareholder wishing to attend a General Meeting of Shareholders shall notify the Company by the date mentioned in the notice to the meeting, which may not be more than ten (10) days before the meeting.
In addition to the domicile of the company the General meetings may be held in Tampere or Helsinki.”
The minutes of the Annual General Meeting are made available no later than 29 March 2023 on the website of Robit Plc at https://www.robitgroup.com/investor/corporate-governance/general-meeting/.
Tampere, 15 March 2023
Board of Directors
Harri Sjöholm, Chairman
+358 400 622 092
Nasdaq Helsinki Ltd
Robit is the expert focused on high quality drilling consumables for mining and construction markets globally to help you drill Further. Faster. Robit strives to be world number one company in drilling consumables. Through our high and proven quality Top Hammer, Down the Hole and Geotechnical products, and our expert services, we deliver saving in drilling costs to our customers. Robit has its own sales and service points in seven countries and an active distributor network through which it sells to more than 100 countries. Robit’s manufacturing units are located in Finland, South Korea, Australia and the UK. Robit’s shares are listed on Nasdaq Helsinki Ltd. Further information is available at www.robitgroup.com.To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Vereniging Aegon to participate in current share buyback program8.12.2023 20:00:00 CET | Press release
The Hague, December 8, 2023 - Aegon has entered into an agreement with its largest shareholder, Vereniging Aegon, to partially participate in Aegon’s current EUR 1.5 billion share buyback program. The repurchase of shares from Vereniging Aegon will commence as soon as Aegon has repurchased shares for an amount of EUR 750 million under the buyback program and is expected to run until the end of the share buyback program. Barring unforeseen circumstances, the share buyback is expected to be completed on or before June 30, 2024. As of December 7, Aegon has repurchased 149.8 million shares representing EUR 703.9 million. Aegon began its EUR 1.5 billion share buyback program on July 6, 2023 following the completion of the transaction to combine Aegon’s Dutch pension, life and non-life insurance, banking, and mortgage origination activities with a.s.r., that was announced on July 4, 2023. Vereniging Aegon will participate pro-rata in the share buyback program based on its combined common sha
Clean Motion AB skriver under projektavtal med EU8.12.2023 19:09:01 CET | Pressemelding
Elfordonstillverkaren Clean Motion AB har skrivit under ett projektavtal inom EU Horizon Europe programmet. Projektet GIANTS (Green Intelligent Affordable Nano Transport Solutions) har totalt 23 projektpartners och en total budget på 15,1 miljoner Euro varav 12 miljoner Euro är bidrag från EU. Clean Motion har den tredje största budgeten och kommer att tilldelas ett bidrag från EU på 1,3 miljoner Euro fördelat över projektperioden på 42 månader, med start i januari 2024. Clean Motion AB, en ledare inom utvecklingen av hållbara transportlösningar, är stolta över att meddela sitt deltagande i GIANTS-projektet, finansierat av EU inom ramen för Horizon Europe-programmet. Projektets totala budget uppgår till 15,1 miljoner euro där EU står för 12 miljoner euro. Clean Motions totala budget i projektet är 1,9 miljoner euro med EU-finansiering om 1,3 miljoner euro. Inom projektet som löper från januari 2024 och 42 månader framåt kommer vi att samarbeta med 22 andra partners, bland andra Renault
Wolters Kluwer again recognized as a Leader in Gartner® Magic Quadrant™ for Financial Planning Software8.12.2023 17:50:33 CET | Press release
PRESS RELEASE Wolters Kluwer again recognized as a Leader in Gartner® Magic Quadrant™ for Financial Planning Software Wolters Kluwer CCH Tagetik AI-based financial planning solution empowers finance professionals to make faster and better-informed decisions. New York – Dec. 8, 2023 – Wolters Kluwer, a global leader in professional information, software solutions and services, today announced that it has been recognized as a Leader in the 2023 Gartner Magic Quadrant for Financial Planning Software. Earlier this month, Wolters Kluwer also received recognition as a Leader in the Gartner Magic Quadrant for Financial Close and Consolidation Software. CCH Tagetik Budgeting, Planning and Forecasting software is Wolters Kluwer’s AI-based, enterprise-wide planning solution, which helps global companies facilitate strategic, financial, and operational planning, including supply chain, workforce, and capital expenses. The solution, which supports customers across vertical industries, is particula
Roche's Kadcyla is the first targeted therapy to show significant overall survival benefit in people with HER2-positive early-stage breast cancer with residual invasive disease after neoadjuvant treatment8.12.2023 17:50:00 CET | Press release
Phase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated to date1,2Long-term data also showed continued benefit in invasive disease-free survival for adjuvant Kadcyla compared to Herceptin in this study2These data will be presented as an oral presentation at the 2023 San Antonio Breast Cancer Symposium and included in the official press programme Basel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive long-term follow-up data from the pivotal, phase III KATHERINE study in people with HER2-positive early-stage breast cancer (eBC) who have residual invasive disease following neoadjuvant (before surgery) treatment. A statistically significant and clinically meaningful improvement in overall survival (OS), a secondary endpoint, was observed with adjuvant (post-surgery) Kadcyla® (trastuzumab emtansine) compared to Herceptin® (trastuzumab): at the 7-year landmark OS rates were 89.07% and 84.37
Roche’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation8.12.2023 17:45:00 CET | Press release
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to address resistance to treatment and poor prognosis associated with PIK3CA mutations2-5 These new data are being presented today in an oral presentation at the 2023 San Antonio Breast Cancer Symposium and shared with health authorities Basel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presented today positive results from the Phase III INAVO120 study evaluating inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for people with PIK3CA-mutated, hormone receptor (HR)-positive, HER2-negative, endocrine-resistant, locally advanced or metastatic breast cancer.1 The inavolisib combination reduced the risk of disease worsening or death (progression-free survival; PFS) by 57% compared to palbociclib and fulvestrant alone (15.0 months vs 7.3 months;